Inamed gets breast implant setback; FDA revises guidance
This article was originally published in Clinica
Inamed has said that it intends to forge ahead with plans to eventually market silicone gel implants in the US and is confident of gaining FDA approval, despite failing to win the agency's approval earlier this week. The company's statement comes hot-on-the-heels of the FDA's January 8 release of revised guidelines for breast implant manufacturers.
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.